Kinetic Capital

Kinetic Capital is a private equity and venture capital firm based in Vancouver, Canada, specializing in later-stage, pre-IPO, and buyout investments. The firm employs various investment strategies, including "Value for Growth" and "Break-up Value," to identify opportunities primarily in the life sciences, wireless/cable, fuel cells, information systems/software, medical devices, supply chain management, healthcare, consumer products, publishing, and industrial products sectors. Kinetic Capital typically invests between $1 million and $25 million in companies with enterprise values of $35 million to $100 million and an EBITDA of at least $8 million, often seeking a majority stake in its portfolio companies. Additionally, the firm engages in opportunistic public market investments through its affiliated partnerships, focusing on businesses at the commercialization stage within the global market, particularly in the United States.

Frank D. Barker

Partner

H. Ross, M. Dallas

Partner

22 past transactions

Bluzelle

Initial Coin Offering in 2018
Bluzelle Networks Pte Ltd. develops a decentralized, blockchain-based database platform that distributes data across many nodes, instead of storing all information in a centralized cloud system. It enables renting individuals' computer storage space to earn tokens while dApp developers use tokens to have their dApp's data stored and managed. It caters to software developers and enterprise software architects. Bluzelle Networks Pte Ltd. was founded in 2014 and is based in Singapore with additional office in Vancouver, Canada.

SubDAO Network

Funding Round in 2021
SubDAO Network is a DAO management platform that aims to provide a chain of tools to facilitate DAO’s creation. SubDAO is a DAO infrastructure based on Polkadot, where any decentralized organization is allowed to conveniently create and manage a DAO. SubDAO does not only connect DAO with DApps to realize DAO’s cross-chain management, but also bridges Web 2.0 and Web 3.0.

Usystems

Venture Round in 2007
They're committed to designing and manufacturing world class, quality racking enclosures and cooling products that dramatically reduce noise, heat and costs in data centres and offices. They do this through clear and innovative thinking in our designs and using state-of-the-art manufacturing processes.

CXIP Labs

Seed Round in 2022
CXIP Labs is a developer of NFT infrastructure solutions for the web3 ecosystem.

BlockApps

Series B in 2022
BlockApps, Inc. develops and delivers a blockchain platform for building and deploying Ethereum blockchain applications. It offers BlockApps STRATO, an Ethereum compliant platform for development, deployment, and management of enterprise blockchain applications. The company also provides STRATO consortium blockchain network, an enterprise grade blockchain solution that enables the construction of hybrid private, consortium, and public blockchains. It serves software startups, IT and professional services’ firms, industry owned businesses, and Fortune 500 corporates. The company has a strategic partnership with Optimum. BlockApps, Inc. was founded in 2015 and is headquartered in Brooklyn, New York.

Cere Network

Venture Round in 2021
Cere Network develops blockchain-based customer relationship management (CRM) ecosystem for data integration and collaboration. The company offers a platform, which extracts customer data from monolithic and disparate CRM/ customer data platform (CDP) systems and provides an open micro-services platform for data collaboration and integration between businesses and vendors. It also offers tokens CERE for the payment of services within ecosystem. The company was founded in 2019 and is headquartered in San Francisco, California.

Protiva Biotherapeutics

Series C in 2006
Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid Particle technology, an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), to target cells. The company also develops Hepatitis siRNA products for the treatment of hepatitis B and C. Protiva Biotherapeutics, Inc. has a research and development facility in Vancouver, Canada. The company was founded in 2000 and is based in Seattle, Washington. As of May 30, 2008, Protiva Biotherapeutics, Inc. operates as a subsidiary of Tekmira Pharmaceuticals Corp.

VisCardia

Series B in 2017
Viscardia, Inc., a medical device company, develops and commercializes a medical device therapy for patients with medical refractory heart failure. The company develops a fully implantable electronic, sensor, and electrode system for delivering chronic electrical stimulation for mediating thoracic pressure augmentation. Its therapy uses the patient’s own thoracic musculature to improve cardiac filling and output, and relieve symptoms resulting from hemodynamic insufficiency. The company was incorporated in 2015 and is based in Beaverton, Oregon.

Eximchain

Initial Coin Offering in 2018
Eximchain provides a digital platform that makes the global sourcing process easy for small-and-medium sized businesses. It offers a one-stop service, including data-driven analysis, customized recommendations, and direct connections with suppliers. The company builds a data driven reputation platform to help the client assess potential supplier's reliability based on transaction history; and creates a digital replica of pen and paper based contract and management process, and stores contracts and proof of performance in the bitcoin blockchain. Eximchain is based in the United States.

Thunder Token, Inc.

Private Placement in 2019
Thunder Token, Inc. develops EVM-compatible public blockchain technology. The company was founded in 2017 and is based in Las Vegas, Nevada.

Cere Network

Private Placement in 2020
Cere Network develops blockchain-based customer relationship management (CRM) ecosystem for data integration and collaboration. The company offers a platform, which extracts customer data from monolithic and disparate CRM/ customer data platform (CDP) systems and provides an open micro-services platform for data collaboration and integration between businesses and vendors. It also offers tokens CERE for the payment of services within ecosystem. The company was founded in 2019 and is headquartered in San Francisco, California.

ThunderCore

Series A in 2019
ThunderCore is a fast, high performance EVM-compatible public blockchain with fully decentralized trust that brings scale to decentralized applications - with higher throughput, faster confirmation times, and lower costs. Based on years of groundbreaking research by Professors Shi and Pass of Cornell University, ThunderCore uses a breakthrough consensus protocol that overcomes the fundamental limitations of Nakamoto consensus. The result maintains fully decentralized trust while significantly improving performance.​

Dtravel

Seed Round in 2021
Dtravel is a decentralized platform for the home-sharing economy facilitating short and long-term stays payable with cryptocurrency and traditional payment methods.

Convergence Finance

Seed Round in 2021
Convergence Finance is a decentralized interchangeable asset protocol.

Reef Finance

Seed Round in 2020
Reef Finance LLC develops Polkadot based cross-chain DeFi operating platform. The company provides a liquidity aggregator and yield engine that enables trading with access to liquidity from both CEXes and DEXes while offering smart lending, borrowing, staking, mining through artificial intelligence (AI) based personalized yield engine. The company was incorporated in 2011 and is based in Wilmington, Delaware.

Protiva Biotherapeutics

Venture Round in 2007
Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid Particle technology, an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), to target cells. The company also develops Hepatitis siRNA products for the treatment of hepatitis B and C. Protiva Biotherapeutics, Inc. has a research and development facility in Vancouver, Canada. The company was founded in 2000 and is based in Seattle, Washington. As of May 30, 2008, Protiva Biotherapeutics, Inc. operates as a subsidiary of Tekmira Pharmaceuticals Corp.

Linear Finance

Seed Round in 2020
Linear Finance owns and operates an application for cross-chain compatible, decentralized delta-one asset protocol to create, manage, and trade synthetic assets with unlimited liquidity. The company caters to bitcoin, crude oil, coffee, market indices, e-sports, and sustainability industries. Linear Finance is headquartered in New Territories, Hong Kong.

Eximchain

Private Placement in 2018
Eximchain provides a digital platform that makes the global sourcing process easy for small-and-medium sized businesses. It offers a one-stop service, including data-driven analysis, customized recommendations, and direct connections with suppliers. The company builds a data driven reputation platform to help the client assess potential supplier's reliability based on transaction history; and creates a digital replica of pen and paper based contract and management process, and stores contracts and proof of performance in the bitcoin blockchain. Eximchain is based in the United States.

Opium Team

Seed Round in 2020
opium.network offers a blockchain network for financial applications. The company provides decentralized protocol for trade settlement, derivative trading, exchange, custom options, and risk management. The company allows the user to create derivative, use oracle to provide the price of asset, and create portfolios and trade in ecosystems. The company also offers smart contracts, crypto wallet, and API. opium.network was founded in 2018 and is based in Rotterdam, the Netherlands.

AgInfoLink

Series A in 2007
AgInfoLink Inc. designs and develops traceability solutions for the food industry. It offers data collection, secure data transmission, data warehousing, reporting, and analysis tools for linking information for individual animal management, regulatory compliance, and business performance. The company provides Pony Express, a data sharing solution to create and customize a data sharing network for supply chain; BeefLink, a personal computer-based data collection and management system to capture and store data automatically from RFID and barcode tags, scales, and other devices; AgInfoReports and AgInfoSheets reporting systems; and AgMobile, a handheld unit and wireless RFID reader that allows livestock producers to identify animals, record data, and reference historical data. AgInfoLink, Inc. also offers CattleCard, a data collection solution, for customers without computers, to collect group data and individual data using a barcode label sticker and RFID identifier; Tag Tracker, a rugged hand-held wireless RFID reader reads an RFID tag and communicates with a base station; and Animal Logger, a solution for collecting NAIS required and basic animal movement information, as well as WebReporting and Decision Pro tools, and processed verification programs. It serves state regulators, meat processors, retail/foodservice, and livestock producers. The company was founded in 1997 and is based in Longmont, Colorado.

Jet Protocol Holdings

Seed Round in 2021
Jet Protocol Holdings offers a borrowing agreement focusing on innovative loan products and cross-chain interest rate arbitrage, allowing users to simplify borrowing and lending transactions.